Carolinas Rheumatology is categorized under Hospitals in Florence, SC and active since 2007.
Carolinas Rheumatology was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Darcy Craven at the company’s single location by writing to 805 Pamplico Highway # A125, Florence, South Carolina SC 29505 or by phoning (843) 206-0257. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Carolinas Rheumatology |
| Contact Person: | Darcy Craven |
| Address: | 805 Pamplico Highway # A125, Florence, South Carolina 29505 |
| Phone Number: | (843) 206-0257 |
| Website Address: | carolinashospital.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 6211110 |
| Share This Business: |
Carolinas Rheumatology was started in 2007 to provide professional Hospitals under the SIC code 8062 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Darcy Craven for inquiries that concern Carolinas Rheumatology by calling the company number (843) 206-0257, as your correspondence is most welcome. Additionally, the physical location of the single location of Carolinas Rheumatology can be found at the coordinates 34.15842,-79.75379 as well as the street address 805 Pamplico Highway # A125 in Florence, South Carolina 29505.
For its online presence, you may visit Carolinas Rheumatology’s website at carolinashospital.com and engage with its social media outlets through on Twitter and on Facebook.